Fund strategy US-domiciled closed-end special situation fund with a target 25%+ net IRR and investment focus of 20-25 million into 10-12 portfolio companies, indicating a potential appetite for co-investment opportunities and strategic exits.

Industry focus Concentrated on software, semiconductor, and medical devices in the US, suggesting strong cross-sell potential with portfolio companies or fund-level investments in adjacent tech sectors.

Track record History of top-quartile performance and substantial exits (1.4B returned from 85 investments with 24 IPOs) signaling credibility and potential interest in high-growth late-stage or microcap opportunities for scale and exits.

Team depth Experience spans over 60 years in management and 45 years in venture investment, including multiple CEO assignments, which may translate to valuable strategic partnerships, board seats, and operational support for portfolio firms.

Investment outcomes Past funds’ performance and a focus on organic growth plus strategic mergers indicate openness to proprietary deal sourcing, value-add collaborations, and potential co-investment with other firms to amplify returns.